Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PDI Identifies 40 Potential Products For Sales Through LifeCycle X-Tension

Executive Summary

Professional Detailing, Inc. has identified 40 products that could be marketed through its LifeCycle X-Tension service, CEO Charles Saldarini said.
Advertisement

Related Content

PDI/Bayer Detailing Focuses On Cipro, Avelox After Baycol Withdrawal
PDI/Bayer Detailing Focuses On Cipro, Avelox After Baycol Withdrawal
PDI's Ceftin Primary Care Sales Force Could Transition To Another Product
PDI's Ceftin Primary Care Sales Force Could Transition To Another Product
Ranbaxy Generic Ceftin May Clear FDA After USP Monograph Revision
Ranbaxy Generic Ceftin May Clear FDA After USP Monograph Revision
Baycol Withdrawal Gives Boost To Pravachol; Will Crestor NDA Be Affected?
Pfizer/PDI
Novartis Lotensin
Advertisement
UsernamePublicRestriction

Register

PS038372

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel